PPARG and metabolic syndrome: Other possible pharmacological therapies include anti-diabetic drugs such as metformin, SGLT2 inhibitors, PPARγ and GLP-1 agonists, lipid lowering medications mainly statins as well as renin angiotensin system inhibitors due to their effect in reducing cardiovascular risk especially in the presence of dyslipidemia, diabetes and hypertension.